SCOPE 2022

Clinical management platform enables vendor visibility: Strategikon Pharma

By Jenni Spinner contact

- Last updated on GMT

(filo/iStock via Getty Images Plus)
(filo/iStock via Getty Images Plus)

Related tags: Clinical trials software, Data management, Research, Software, Clinical trials

Vision, part of the company’s Clinical Maestro platform of software-as-a-solution applications, enables study teams to manage clinical vendor oversight.

Strategikon Pharma announced at the 2022 Summit for Clinical Ops Executives (SCOPE)​ an enhancement to its Clinical Maestro Sponsor Edition platform: Vision, geared toward R&D vendor management. The update is designed to deliver a clinical vendor governance solution that enables pharma users to oversee R&D and manage vendor performance.

Vendor management is an activity that engages multiple departments (including outsourcing, procurement, finance, quality, and clin ops). Handling the complex, disparate data can be challenging and frustrating, making it difficult to make informed decisions efficiently.

OSP_StrategikonVision_screenshot
(Image: Strategikon Pharma)

We designed the Clinical Maestro Sponsor Edition to address all the major pain points of clinical business operations through cutting-edge technology: clinical study planning and budgeting, outsourcing management, contract tracking, and forecasting​,” said Anca Copaescu, founder and CEO of Strategikon Pharma. “With the addition of Vision, we are completing the cycle by bringing new vendor qualification, existing vendor risk scoring and performance management under the same ecosystem, giving strategic sourcing managers, quality groups, and outsourcing teams unprecedented transparency into all key aspects of vendor governance​.”

Vision is intended to provide the crucial elements of vendor quality and strategic management (contracts, operational performance, quality, financial key performance indicators) in one place. According to Strategikon, it enables visibility into vendors’ activity details across studies, departments, therapeutic areas, and geographical locations through integrated data and dashboards.

Clinical Maestro is a software-as-a-service (SaaS) solution designed to improve information management for stakeholders in clinical trial development, including pharmaceutical companies and their R&D partners. It is intended to facilitate budgeting, sourcing, and management functions faster, more accurately, and more easily than other technologies.

Strategikon Pharma is among the companies exhibiting at this year's Summit for Clinical Ops Executives (SCOPE), taking place February 7-10 in Orlando, Florida, and online. For more information about the event, visit www.scopesummit.com

Related news

Related products

show more

Governing and Maintaining Clinical Data Standards

Governing and Maintaining Clinical Data Standards

Veeva | 10-May-2022 | Technical / White Paper

Investing in data standards plays a huge role in improving the quality of clinical studies. But often, people don’t use the standards correctly, there...

What the Best Clinical Study Build Pros Do

What the Best Clinical Study Build Pros Do

Formedix | 09-May-2022 | Technical / White Paper

Getting your clinical study designed and built ready for data collection takes A LOT of work and expertise… you've got to do all your CRF designs;...

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 18-Apr-2022 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Related suppliers

Follow us

Products

View more

Webinars